 |
|
Commentary on “Remission in pediatric Graves’ disease treated with antithyroid drug and the risk factors associated with relapse”
Ji Hyun Kim
Ann Pediatr Endocrinol Metab. 2022;27(4):245-246. Published online 2022 Dec 31 DOI: https://doi.org/10.6065/apem.2222019edi04
|
|
Citations to this article as recorded by
 Updates in the Management of Graves Disease in Children
Yun Jeong Lee
The Ewha Medical Journal.2023;[Epub] CrossRef
|